TIR8/SIGIRR is an interleukin-1 receptor/toll like receptor Family member with regulatory functions in inflammation and immunity

Federica Riva, Eduardo Bonavita, Elisa Barbati, Marta Muzio, Alberto Mantovani, Cecilia Garlanda

Research output: Contribution to journalArticle

Abstract

Interleukin-1R like receptors (ILRs) andToll Like Receptors (TLRs) are key receptors of innate immunity, inflammation, and orientation of the adaptive response. They belong to a super-family characterized by the presence of a conserved intracellular domain, theToll/IL-1R (TIR) domain, which is involved in the activation of a signaling cascade leading to activation of transcription factors associated to inflammation.The activation of inflammatory responses and immunity by ILRs orTLRs signaling is potentially detrimental for the host in acute and chronic conditions and is tightly regulated at different levels by receptor antagonists, decoy receptors or signaling molecules, and miRNAs. Recent evidence suggests that the ILRs family member TIR8 (also known as SIGIRR) is a regulatory protein acting intracellularly to inhibit ILRs and TLRs signaling. In particular, current evidence suggests that TIR8/SIGIRR dampensTLRs-mediated activation and inhibits signaling receptor complexes of IL-1 family members associated withTh1 (IL-18),Th2 (IL-33), andTh17 (IL-1) differentiation. Studies with Tir8/Sigirr-deficient mice showed that the ability to dampen signaling from ILRs and TLRs family members makesTIR8/SIGIRR a key regulator of inflammation. Here, we summarize our current understanding of the structure and function of TIR8/SIGIRR, focusing on its role in different pathological conditions, ranging from infectious and sterile inflammation, to autoimmunity and cancer-related inflammation.

Original languageEnglish
Article numberArticle 322
JournalFrontiers in Immunology
Volume3
Issue numberOCT
DOIs
Publication statusPublished - 2012

Fingerprint

Interleukin-1 Receptors
Toll-Like Receptors
Interleukins
Immunity
Inflammation
Interleukin-18
Aptitude
MicroRNAs
Autoimmunity
Innate Immunity
Transcription Factors
Neoplasms
Proteins

Keywords

  • Cytokine
  • Infection
  • Inflammation
  • Inflammation-associated cancer
  • Interleukin-1
  • Toll like receptors

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

@article{039c722a42ca4034bd82e0caa3a9d849,
title = "TIR8/SIGIRR is an interleukin-1 receptor/toll like receptor Family member with regulatory functions in inflammation and immunity",
abstract = "Interleukin-1R like receptors (ILRs) andToll Like Receptors (TLRs) are key receptors of innate immunity, inflammation, and orientation of the adaptive response. They belong to a super-family characterized by the presence of a conserved intracellular domain, theToll/IL-1R (TIR) domain, which is involved in the activation of a signaling cascade leading to activation of transcription factors associated to inflammation.The activation of inflammatory responses and immunity by ILRs orTLRs signaling is potentially detrimental for the host in acute and chronic conditions and is tightly regulated at different levels by receptor antagonists, decoy receptors or signaling molecules, and miRNAs. Recent evidence suggests that the ILRs family member TIR8 (also known as SIGIRR) is a regulatory protein acting intracellularly to inhibit ILRs and TLRs signaling. In particular, current evidence suggests that TIR8/SIGIRR dampensTLRs-mediated activation and inhibits signaling receptor complexes of IL-1 family members associated withTh1 (IL-18),Th2 (IL-33), andTh17 (IL-1) differentiation. Studies with Tir8/Sigirr-deficient mice showed that the ability to dampen signaling from ILRs and TLRs family members makesTIR8/SIGIRR a key regulator of inflammation. Here, we summarize our current understanding of the structure and function of TIR8/SIGIRR, focusing on its role in different pathological conditions, ranging from infectious and sterile inflammation, to autoimmunity and cancer-related inflammation.",
keywords = "Cytokine, Infection, Inflammation, Inflammation-associated cancer, Interleukin-1, Toll like receptors",
author = "Federica Riva and Eduardo Bonavita and Elisa Barbati and Marta Muzio and Alberto Mantovani and Cecilia Garlanda",
year = "2012",
doi = "10.3389/fimmu.2012.00322",
language = "English",
volume = "3",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S.A.",
number = "OCT",

}

TY - JOUR

T1 - TIR8/SIGIRR is an interleukin-1 receptor/toll like receptor Family member with regulatory functions in inflammation and immunity

AU - Riva, Federica

AU - Bonavita, Eduardo

AU - Barbati, Elisa

AU - Muzio, Marta

AU - Mantovani, Alberto

AU - Garlanda, Cecilia

PY - 2012

Y1 - 2012

N2 - Interleukin-1R like receptors (ILRs) andToll Like Receptors (TLRs) are key receptors of innate immunity, inflammation, and orientation of the adaptive response. They belong to a super-family characterized by the presence of a conserved intracellular domain, theToll/IL-1R (TIR) domain, which is involved in the activation of a signaling cascade leading to activation of transcription factors associated to inflammation.The activation of inflammatory responses and immunity by ILRs orTLRs signaling is potentially detrimental for the host in acute and chronic conditions and is tightly regulated at different levels by receptor antagonists, decoy receptors or signaling molecules, and miRNAs. Recent evidence suggests that the ILRs family member TIR8 (also known as SIGIRR) is a regulatory protein acting intracellularly to inhibit ILRs and TLRs signaling. In particular, current evidence suggests that TIR8/SIGIRR dampensTLRs-mediated activation and inhibits signaling receptor complexes of IL-1 family members associated withTh1 (IL-18),Th2 (IL-33), andTh17 (IL-1) differentiation. Studies with Tir8/Sigirr-deficient mice showed that the ability to dampen signaling from ILRs and TLRs family members makesTIR8/SIGIRR a key regulator of inflammation. Here, we summarize our current understanding of the structure and function of TIR8/SIGIRR, focusing on its role in different pathological conditions, ranging from infectious and sterile inflammation, to autoimmunity and cancer-related inflammation.

AB - Interleukin-1R like receptors (ILRs) andToll Like Receptors (TLRs) are key receptors of innate immunity, inflammation, and orientation of the adaptive response. They belong to a super-family characterized by the presence of a conserved intracellular domain, theToll/IL-1R (TIR) domain, which is involved in the activation of a signaling cascade leading to activation of transcription factors associated to inflammation.The activation of inflammatory responses and immunity by ILRs orTLRs signaling is potentially detrimental for the host in acute and chronic conditions and is tightly regulated at different levels by receptor antagonists, decoy receptors or signaling molecules, and miRNAs. Recent evidence suggests that the ILRs family member TIR8 (also known as SIGIRR) is a regulatory protein acting intracellularly to inhibit ILRs and TLRs signaling. In particular, current evidence suggests that TIR8/SIGIRR dampensTLRs-mediated activation and inhibits signaling receptor complexes of IL-1 family members associated withTh1 (IL-18),Th2 (IL-33), andTh17 (IL-1) differentiation. Studies with Tir8/Sigirr-deficient mice showed that the ability to dampen signaling from ILRs and TLRs family members makesTIR8/SIGIRR a key regulator of inflammation. Here, we summarize our current understanding of the structure and function of TIR8/SIGIRR, focusing on its role in different pathological conditions, ranging from infectious and sterile inflammation, to autoimmunity and cancer-related inflammation.

KW - Cytokine

KW - Infection

KW - Inflammation

KW - Inflammation-associated cancer

KW - Interleukin-1

KW - Toll like receptors

UR - http://www.scopus.com/inward/record.url?scp=84874217124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874217124&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2012.00322

DO - 10.3389/fimmu.2012.00322

M3 - Article

C2 - 23112799

AN - SCOPUS:84874217124

VL - 3

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - OCT

M1 - Article 322

ER -